Phase 3 Study of Subcutaneous Bortezomib, Thalidomide, and Prednisolone Consolidation after Subcutaneous Bortezomib-Based Induction and Autologous Stem Cell Transplantation in Patients with Previously Untreated Multiple Myeloma: the VCAT Study
Leukemia & lymphoma/Leukemia and lymphoma（2019）
Key words
Bortezomib,multiple myeloma,consolidation,phase 3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined